Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
The RSV shot — the first ever drug using mRNA technology approved for a disease other than COVID — gives it another ...
The Cambridge biotech said Friday that the European Patent Office has upheld the validity of one of its key patents, a ...
The government’s push to fund the development of an mRNA bird flu vaccine comes amid an H5N1 outbreak in cattle and poultry ...
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing ...
The jury found that AstraZeneca's Tagrisso violated Pfizer's Wyeth unit's patent rights under US patents 10,603,314 and ...
Moderna (MRNA) stock gains as the U.S. is close to fund a late-stage trial for the company's messenger-RNA-based ...
"Moderna's counsel argued that the pledge made by Moderna did not constitute consent at all with respect to Pfizer and ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...